Effects of variable domain orientation on anti‐HER2 single‐chain variable fragment antibody expressed in the Escherichia coli cytoplasm-Reference-Cited by-同舟云学术

Effects of variable domain orientation on anti‐HER2 single‐chain variable fragment antibody expressed in the Escherichia coli cytoplasm

Published:2020-11-20 Issue:2 Volume:37 Page:
ISSN:8756-7938
Container-title:Biotechnology Progress
language:en
Short-container-title:Biotechnol Progress

Author:

Koçer İlkay¹²^ORCID,Cox Emily C.³,DeLisa Matthew P.²³^ORCID,Çelik Eda¹⁴^ORCID

Affiliation:

1. Department of Chemical Engineering Hacettepe University Ankara Turkey

2. Robert F. Smith School of Chemical and Biomolecular Engineering Cornell University Ithaca New York USA

3. Biological and Biomedical Sciences Cornell University College of Veterinary Medicine Ithaca New York USA

4. Institute of Science, Division of Bioengineering Hacettepe University Ankara Turkey

Funder

National Institutes of Health

Defense Threat Reduction Agency

National Science Foundation

Türkiye Bilimsel ve Teknolojik Araştirma Kurumu

Publisher

Wiley

Subject

Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/btpr.3102

Reference53 articles.

1. HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches

2. HER2-Positive Breast Cancer

3. Overview of the trastuzumab (Herceptin) anti‐HER2 monoclonal antibody clinical program in HER2‐overexpressing metastatic breast cancer. Herceptin multinational investigator study group;Shak S;Semin Oncol,1999

4. FDA approves pertuzumab

5. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Escherichia coli in the production of biopharmaceuticals;Biotechnology and Applied Biochemistry;2024-09-08

2. Efficient generation of recombinant anti‐HER2 scFv with high yield and purity using a simple method;Biotechnology Journal;2024-07

3. Development of an Anti-HER2 Single-Chain Variable Antibody Fragment Construct for High-Yield Soluble Expression in Escherichia coli and One-Step Chromatographic Purification;Biomolecules;2023-10-11

4. Enhanced production and single step purification of biologically active recombinant anti-IL6 scFv from Escherichia coli inclusion bodies;Process Biochemistry;2023-10

5. Protein engineering of antibody fragments for pharmaceutical production;Applied Physics Reviews;2023-09-01